Finance

Lists
Why is 688578 down 3,16%?
Dive Deeper
688578:SHA
Shanghai Allist Pharmaceuticals Co Ltd
CN¥81,79
-3,16%
(-2,67) 1D
16 Okt., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688578...
Open
CN¥85,20
High
CN¥85,63
Low
CN¥80,92
Mkt. cap
36,81 mjd
Avg. vol.
6,82 m
Volume
10,16 m
Dividend
1,47%
Quarterly dividend
CN¥0,30
Ex-dividend date
02 Sep. 2026
P/E ratio
13,74
52-wk high
CN¥138,30
52-wk low
CN¥75,55
EPS
CN¥5,95
No. of employees
2 k
Open
CN¥85,20
High
CN¥85,63
Low
CN¥80,92
Mkt. cap
36,81 mjd
Avg. vol.
6,82 m
Volume
10,16 m
Dividend
1,47%
Quarterly dividend
CN¥0,30
Ex-dividend date
02 Sep. 2026
P/E ratio
13,74
52-wk high
CN¥138,30
52-wk low
CN¥75,55
EPS
CN¥5,95
No. of employees
2 k
News stories
From web sources and news partners
About Shanghai Allist Pharmaceuticals Co Ltd
CEO-
Employees2,27 k
Founded22 Mrt. 2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,36 mjd
1,45 mjd
1,58 mjd
1,74 mjd
Cost of goods sold
45,38 m
44,82 m
80,59 m
90,24 m
Cost of revenue
45,38 m
44,82 m
80,59 m
90,24 m
Research and development expenses
112,23 m
100,54 m
113,72 m
112,11 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
564,71 m
651,83 m
646,12 m
667,07 m
Operating expense
695,25 m
771,29 m
779,22 m
805,13 m
Total operating expenses
740,63 m
816,11 m
859,80 m
895,38 m
Operating income
618,62 m
638,21 m
723,97 m
840,64 m
Other non operating income
-3,11 m
2,18 m
-4,07 m
4,51 m
EBT including unusual items
653,24 m
656,24 m
741,46 m
1,06 mjd
EBT excluding unusual items
636,19 m
652,61 m
742,22 m
861,81 m
Income tax expense
88,70 m
82,91 m
105,41 m
154,67 m
Effective tax rate
13,58%
12,63%
14,22%
14,60%
Other operating expenses
18,47 m
18,97 m
20,01 m
24,71 m
Net income
564,54 m
573,33 m
636,04 m
904,75 m
Net profit margin
41,53%
39,42%
40,16%
52,12%
Earnings per share
-
-
-
-
Interest and investment income
19,56 m
17,89 m
22,35 m
25,93 m
Interest expense
-47,12 k
-9,69 k
-34,43 k
-31,50 k
Net interest expenses
19,52 m
17,88 m
22,32 m
25,90 m
Depreciation and amortization charges
-
-
-
-
EBITDA
627,70 m
648,03 m
733,79 m
852,49 m
Gain or loss from assets sale
21,12 k
-23,20 k
-
-6,73 k
AI content may include mistakes. Learn more
Google-programme